Vancouver
Anzai K, Ohe M, Shida H, Furuya K, Kogawa K. A Case of Capecitabine-Related Myelodysplastic Syndrome. J CLIN EXP INVEST. 2022;13(1):em00784. https://doi.org/10.29333/jcei/11512
APA
Anzai, K., Ohe, M., Shida, H., Furuya, K., & Kogawa, K. (2022). A Case of Capecitabine-Related Myelodysplastic Syndrome. Journal of Clinical and Experimental Investigations, 13(1), em00784. https://doi.org/10.29333/jcei/11512
AMA
Anzai K, Ohe M, Shida H, Furuya K, Kogawa K. A Case of Capecitabine-Related Myelodysplastic Syndrome. J CLIN EXP INVEST. 2022;13(1), em00784. https://doi.org/10.29333/jcei/11512
Chicago
Anzai, Kazunari, Masashi Ohe, Haruki Shida, Ken Furuya, and Katsuhisa Kogawa. "A Case of Capecitabine-Related Myelodysplastic Syndrome". Journal of Clinical and Experimental Investigations 2022 13 no. 1 (2022): em00784. https://doi.org/10.29333/jcei/11512
Harvard
Anzai, K., Ohe, M., Shida, H., Furuya, K., and Kogawa, K. (2022). A Case of Capecitabine-Related Myelodysplastic Syndrome. Journal of Clinical and Experimental Investigations, 13(1), em00784. https://doi.org/10.29333/jcei/11512
MLA
Anzai, Kazunari et al. "A Case of Capecitabine-Related Myelodysplastic Syndrome". Journal of Clinical and Experimental Investigations, vol. 13, no. 1, 2022, em00784. https://doi.org/10.29333/jcei/11512